Literature DB >> 31301884

Parenteral nutrition prolongs hospital stay in children with nonoperative blunt pancreatic injury: A propensity score weighted analysis.

Cory McLaughlin1, Caron Park2, Christianne J Lane3, Wendy J Mack4, David Bliss5, Jeffrey S Upperman6, Aaron R Jensen7.   

Abstract

BACKGROUND: Blunt pancreatic injury is frequently managed nonoperatively in children. Nutritional support practices - either enteral or parenteral - are heterogeneous and lack evidence-based guidelines. We hypothesized that use of parenteral nutrition (PN) in children with nonoperatively managed blunt pancreatic injury would 1) be associated with longer hospital stay and more frequent complications, and 2) differ in frequency by trauma center type.
METHODS: We conducted a retrospective cohort study using the National Trauma Data Bank (2007-2016). Children (≤18 years) with blunt pancreatic injury were included. Patients were excluded for duodenal injury, mortality <4 days from admission, or laparotomy. We compared children that received versus those that did not receive PN. Logistic regression was used to model patient characteristics, injury severity, and trauma center type as predictors for propensity to receive PN. Treatment groups were balanced using the inverse probability of treatment weights. Outcomes included hospital length of stay, intensive care unit days, incidence of complications and mortality.
RESULTS: 554 children with blunt pancreatic injury were analyzed. PN use declined in adult centers from 2012 to 2016, but remained relatively stable in pediatric centers. Propensity-weighted analysis demonstrated longer median length of stay in patients receiving PN (14 versus 4 days, rate ratio 2.19 [95% CI: 1.97, 2.43]). Children receiving PN also had longer ICU stay (rate ratio 1.73 [95% CI: 1.30, 2.30]). There was no significant difference in incidence of complications or mortality.
CONCLUSIONS: Use of PN in children with blunt pancreatic injury that are managed nonoperatively differs between adult and pediatric trauma centers, and is associated with longer hospital stay. Early enteral feeding should be attempted first, with PN reserved for children with prolonged intolerance to enteral feeds. LEVEL OF EVIDENCE: III, Retrospective cohort.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Pancreatic injury; Parenteral nutrition; Pediatric trauma

Mesh:

Year:  2019        PMID: 31301884      PMCID: PMC6934931          DOI: 10.1016/j.jpedsurg.2019.06.015

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  24 in total

1.  Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.).

Authors:  Stephen A McClave; Beth E Taylor; Robert G Martindale; Malissa M Warren; Debbie R Johnson; Carol Braunschweig; Mary S McCarthy; Evangelia Davanos; Todd W Rice; Gail A Cresci; Jane M Gervasio; Gordon S Sacks; Pamela R Roberts; Charlene Compher
Journal:  JPEN J Parenter Enteral Nutr       Date:  2016-02       Impact factor: 4.016

2.  Validation of the Simplified Motor Score for the prediction of brain injury outcomes after trauma.

Authors:  Jason S Haukoos; Michelle R Gill; Rick E Rabon; Craig S Gravitz; Steven M Green
Journal:  Ann Emerg Med       Date:  2006-11-16       Impact factor: 5.721

3.  ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Energy.

Authors:  K Joosten; N Embleton; W Yan; T Senterre
Journal:  Clin Nutr       Date:  2018-06-18       Impact factor: 7.324

Review 4.  Part 12: Pediatric Advanced Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Authors:  Allan R de Caen; Marc D Berg; Leon Chameides; Cheryl K Gooden; Robert W Hickey; Halden F Scott; Robert M Sutton; Janice A Tijssen; Alexis Topjian; Élise W van der Jagt; Stephen M Schexnayder; Ricardo A Samson
Journal:  Circulation       Date:  2015-11-03       Impact factor: 29.690

Review 5.  Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Pediatric Critically Ill Patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition.

Authors:  Nilesh M Mehta; Heather E Skillman; Sharon Y Irving; Jorge A Coss-Bu; Sarah Vermilyea; Elizabeth Anne Farrington; Liam McKeever; Amber M Hall; Praveen S Goday; Carol Braunschweig
Journal:  JPEN J Parenter Enteral Nutr       Date:  2017-06-02       Impact factor: 4.016

6.  Management of blunt pancreatic trauma in children: Review of the National Trauma Data Bank.

Authors:  Brian R Englum; Brian C Gulack; Henry E Rice; John E Scarborough; Obinna O Adibe
Journal:  J Pediatr Surg       Date:  2016-05-31       Impact factor: 2.545

7.  Operative vs Nonoperative Management of Pediatric Blunt Pancreatic Trauma: Evaluation of the National Trauma Data Bank.

Authors:  Maria Carmen Mora; Kaitlyn E Wong; Jennifer Friderici; Katharine Bittner; Kevin P Moriarty; Lisa A Patterson; Ronald I Gross; Michael V Tirabassi; David B Tashjian
Journal:  J Am Coll Surg       Date:  2015-12-18       Impact factor: 6.113

8.  Early supplemental parenteral nutrition is associated with increased infectious complications in critically ill trauma patients.

Authors:  Matthew J Sena; Garth H Utter; Joseph Cuschieri; Ronald V Maier; Ronald G Tompkins; Brian G Harbrecht; Ernest E Moore; Grant E O'Keefe
Journal:  J Am Coll Surg       Date:  2008-06-24       Impact factor: 6.113

9.  Hazards of benchmarking complications with the National Trauma Data Bank: numerators in search of denominators.

Authors:  Shahrzad Kardooni; Elliott R Haut; David C Chang; Charles A Pierce; David T Efron; Adil H Haider; Peter J Pronovost; Edward E Cornwell
Journal:  J Trauma       Date:  2008-02

10.  Practice variability exists in the management of high-grade pediatric pancreatic trauma.

Authors:  Bindi Naik-Mathuria
Journal:  Pediatr Surg Int       Date:  2016-07-04       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.